CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Sanara Medtech Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Sanara Medtech Inc
1200 Summit Avenue, Suite 414
Phone: (817) 529-2300p:817 529-2300 FORT WORTH, TX  76102  United States Ticker: SMTISMTI

Business Summary
Sanara MedTech Inc. is a medical technology company. The Company is focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical, chronic wound and skincare markets. It has products across surgical and chronic wound care applications and has multiple products in its pipeline. Its surgical products include CellerateRX Surgical Activated Collagen, TEXAGEN, BiFORM, AMPLIFY and ALLOCYTE, FORTIFY TRG Tissue Repair Graft, and FORTIFY FLOWABLE Extracellular Matrix are used in a range of surgical specialties to help promote patient healing and reduce the risk of complications. Its chronic wound care products include HYCOL Hydrolyzed Collagen, BIAKOS Antimicrobial Skin and Wound Cleanser and BIAKOS Antimicrobial Wound Gel, are targeted for use across the post-acute continuum of care, including home health, hospice, physician offices, podiatrists, retail, skilled nursing facilities and wound care clinics.
(Source: 10-K)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
9/30/202312/31/2022YesYes---

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Executive Chairman of the Board Ronald T.Nixon 67 5/17/2019 3/1/2019
Chief Executive Officer Zachary B.Fleming 48 1/1/2022 5/28/2019
Chief Financial Officer Michael D.McNeil 58 4/11/2018 4/11/2018
5 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Wound Care Innovations, LLC 6400 North Andrews Avenue Fort Lauderdale FL United States
Scendia Biologics LLC 111 W Jefferson St Orlando FL United States
Precision Healing, Inc. 275 Washington Street Newton MA United States

Business Names
Business Name
Cellerate, LLC
Precision Healing, Inc.
Precision Healing, LLC
10 additional Business Names available in full report.

General Information
Number of Employees: 101 (As of 12/31/2022)
Outstanding Shares: 8,538,489 (As of 11/13/2023)
Shareholders: 271
Stock Exchange: NASD
Federal Tax Id: 592220004


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, March 18, 2024